account/PRNewswire/ -- Abbott (NYSE: ABT) today announced that it has received CE Mark (Conformite Europeenne) for its new FreeStyle InsuLinx Blood Glucose Monitoring System,(1,2) the first blood glucose monitoring device from Abbott that includes a mealtime...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Abbott's New FreeStyle InsuLinx Blood Glucose Monitoring System With Insulin Calculator Receives CE Mark
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account